相关实验视频
Updated: Apr 13, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
帕金森病中亚thalamic活动的不对称性:局部场势之间的相幅合
Tommaso Bocci1,2, Rosanna Ferrara1, Tommaso Albizzati3
1'Aldo Ravelli' Research Center for Neurotechnology and Experimental Neurotherapeutics, Department of Health Sciences, University of Milan, 20142 Milan, Italy.
帕金森病患者的大脑不对称性显示出明显的多巴胺基神经元活动. 阶段振幅合揭示了对立的半球对levodopa的反应,影响运动症状.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 生物医学工程 生物医学工程
背景情况:
- 帕金森病 (PD) 的运动症状与多巴胺能神经元功能障碍有关.
- 大脑在多巴胺活性中的不对称性及其在PD中的作用仍然不清楚.
- 亚体质核 (STN) 神经生理学显示生物标志物如增高的β活性.
研究的目的:
- 在帕金森病 (PD) 患者中使用阶段-振幅合 (PAC) 调查亚脑核 (STN) 神经活动的半球差异.
- 评估勒沃多巴给药对这些半球间PAC模式的影响.
- 探索PAC不对称性与PD运动症状改善之间的关系.
主要方法:
- 在24名PD患者中从STN记录本地现场潜力记录.
- 在两个半球不同频段 (贝塔,低,中,高) 之间的相振幅合 (PAC) 的分析.
- 在OFF和ON状态下的PAC的比较 (莱沃多巴给药前和后).
主要成果:
- 在左侧和右侧STN之间观察到beta-phase-amplitude coupling (PAC) 的显著不对称性.
- 莱沃多巴的使用对两个半球的PAC产生了相反的影响,与运动症状的减少相关.
- 在高频率和高贝塔振荡之间的高PAC在右STN (OFF) 中逆转为低PAC (ON),而左STN显示相反的模式.
结论:
- STN PAC中的半球不对称性是帕金森病的一个关键特征.
- 观察到的对立的半球对利沃多巴的反应表明,在运动症状控制的基础上存在着不同的神经机制.
- 这些发现对开发适应性深度大脑刺激 (DBS) 策略有影响,这些策略是针对个别PD患者量身定制的.
更多相关视频
08:25Combined Invasive Subcortical and Non-invasive Surface Neurophysiological Recordings for the Assessment of Cognitive and Emotional Functions in Humans
Published on: May 19, 2016
10:46Acute In Vivo Electrophysiological Recordings of Local Field Potentials and Multi-unit Activity from the Hyperdirect Pathway in Anesthetized Rats
Published on: June 22, 2017
相关概念视频
Neural Regulation
Propagation of Action Potentials
Neurons (nerve cells) have a resting membrane potential, with a slightly negative charge inside compared to outside. This is maintained by ion channels, such as sodium (Na+) and potassium (K+) channels, which control the flow of ions. When a stimulus, like a touch or a signal from another neuron, triggers the neuron, sodium channels open, allowing sodium ions to...
Postsynaptic Potential (PSP)
There are two types of receptors: ionotropic and metabotropic.
The ionotropic receptor is the membrane protein that has an...
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...